These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 29759721)
21. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy. Loughlin G; Avila P; Martinez-Ferrer JB; Alzueta J; Vinolas X; Brugada J; Arizon JM; Fernandez-Lozano I; García-Campo E; Basterra N; Fernandez De La Concha J; Arenal A Europace; 2017 Nov; 19(11):1818-1825. PubMed ID: 28339565 [TBL] [Abstract][Full Text] [Related]
22. Should Primary Prevention ICDs Still Be Placed in Patients with Non-ischemic Cardiomyopathy? A Review of the Evidence. Ganga HV; Maan A; Kevin Heist E Curr Cardiol Rep; 2018 Mar; 20(5):31. PubMed ID: 29574588 [TBL] [Abstract][Full Text] [Related]
23. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients. Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657 [TBL] [Abstract][Full Text] [Related]
24. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis. Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432 [TBL] [Abstract][Full Text] [Related]
25. Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis. Alba AC; Foroutan F; Duero Posada J; Battioni L; Schofield T; Alhussein M; Agoritsas T; Spencer FA; Guyatt G Heart; 2018 Feb; 104(3):230-236. PubMed ID: 28780582 [TBL] [Abstract][Full Text] [Related]
26. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT. Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ; Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234 [TBL] [Abstract][Full Text] [Related]
27. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276 [TBL] [Abstract][Full Text] [Related]
28. The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta-analysis. Long YX; Hu Y; Cui DY; Hu S; Liu ZZ Pacing Clin Electrophysiol; 2021 Feb; 44(2):225-234. PubMed ID: 33372697 [TBL] [Abstract][Full Text] [Related]
29. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care? Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425 [TBL] [Abstract][Full Text] [Related]
30. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis. Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401 [TBL] [Abstract][Full Text] [Related]
31. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial. Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754 [TBL] [Abstract][Full Text] [Related]
32. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis. Shah RM; Patel D; Molnar J; Ellenbogen KA; Koneru JN Europace; 2015 Feb; 17(2):267-73. PubMed ID: 25164431 [TBL] [Abstract][Full Text] [Related]
33. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490 [TBL] [Abstract][Full Text] [Related]